268 related articles for article (PubMed ID: 33068124)
1. New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
Castillo AF; Orlando UD; Maloberti PM; Prada JG; Dattilo MA; Solano AR; Bigi MM; Ríos Medrano MA; Torres MT; Indo S; Caroca G; Contreras HR; Marelli BE; Salinas FJ; Salvetti NR; Ortega HH; Lorenzano Menna P; Szajnman S; Gomez DE; Rodríguez JB; Podesta EJ
Cell Mol Life Sci; 2021 Mar; 78(6):2893-2910. PubMed ID: 33068124
[TBL] [Abstract][Full Text] [Related]
2. The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.
Orlando UD; Garona J; Ripoll GV; Maloberti PM; Solano ÁR; Avagnina A; Gomez DE; Alonso DF; Podestá EJ
PLoS One; 2012; 7(7):e40794. PubMed ID: 22808264
[TBL] [Abstract][Full Text] [Related]
3. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
[TBL] [Abstract][Full Text] [Related]
4. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
5. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
[TBL] [Abstract][Full Text] [Related]
6. Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.
Orlando UD; Castillo AF; Dattilo MA; Solano AR; Maloberti PM; Podesta EJ
Oncotarget; 2015 Dec; 6(40):42632-50. PubMed ID: 26536660
[TBL] [Abstract][Full Text] [Related]
7. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
Ye X; Zhang Y; Wang X; Li Y; Gao Y
IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.
Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F
J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
Maloberti PM; Duarte AB; Orlando UD; Pasqualini ME; Solano AR; López-Otín C; Podestá EJ
PLoS One; 2010 Nov; 5(11):e15540. PubMed ID: 21085606
[TBL] [Abstract][Full Text] [Related]
11. Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1.
Kwon YS; Lee MG; Baek J; Kim NY; Jang H; Kim S
Biochem Pharmacol; 2021 Oct; 192():114718. PubMed ID: 34358518
[TBL] [Abstract][Full Text] [Related]
12. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.
Zhou L; Song Z; Hu J; Liu L; Hou Y; Zhang X; Yang X; Chen K
Theranostics; 2021; 11(2):841-860. PubMed ID: 33391508
[TBL] [Abstract][Full Text] [Related]
13. Regulation and role of Acyl-CoA synthetase 4 in glial cells.
Dattilo MA; Benzo Y; Herrera LM; Prada JG; Lopez PF; Caruso CM; Lasaga M; García CI; Paz C; Maloberti PM
J Steroid Biochem Mol Biol; 2021 Apr; 208():105792. PubMed ID: 33246155
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B
Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604
[TBL] [Abstract][Full Text] [Related]
15. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
Kuwata H; Hara S
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
[TBL] [Abstract][Full Text] [Related]
16. Long-chain acyl-CoA synthetase 4 is regulated by phosphorylation.
Smith ME; Saraceno GE; Capani F; Castilla R
Biochem Biophys Res Commun; 2013 Jan; 430(1):272-7. PubMed ID: 23159612
[TBL] [Abstract][Full Text] [Related]
17. Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.
Xiaofei J; Mingqing S; Miao S; Yizhen Y; Shuang Z; Qinhua X; Kai Z
Biochem Biophys Res Commun; 2021 Mar; 545():81-88. PubMed ID: 33548628
[TBL] [Abstract][Full Text] [Related]
18. ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis.
Qiu Y; Wang X; Sun Y; Jin T; Tang R; Zhou X; Xu M; Gan Y; Wang R; Luo H; Liu M; Tang X
Cancer Res; 2024 Jun; 84(11):1856-1871. PubMed ID: 38471082
[TBL] [Abstract][Full Text] [Related]
19. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells.
Dattilo MA; Benzo Y; Herrera LM; Prada JG; Castillo AF; Orlando UD; Podesta EJ; Maloberti PM
Sci Rep; 2019 Jul; 9(1):10324. PubMed ID: 31311992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
